Markets

Is BioTelemetry (BEAT) Stock Outpacing Its Medical Peers This Year?

Investors focused on the Medical space have likely heard of BioTelemetry (BEAT), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of BEAT and the rest of the Medical group's stocks.

BioTelemetry is one of 817 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BEAT is currently sporting a Zacks Rank of #1 (Strong Buy).

The Zacks Consensus Estimate for BEAT's full-year earnings has moved 3.07% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Based on the most recent data, BEAT has returned 66.42% so far this year. Meanwhile, stocks in the Medical group have gained about 0.35% on average. This shows that BioTelemetry is outperforming its peers so far this year.

To break things down more, BEAT belongs to the Medical Services industry, a group that includes 34 individual companies and currently sits at #52 in the Zacks Industry Rank. On average, this group has gained an average of 23.12% so far this year, meaning that BEAT is performing better in terms of year-to-date returns.

BEAT will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

BioTelemetry, Inc. (BEAT): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More